Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3012657rdf:typepubmed:Citationlld:pubmed
pubmed-article:3012657lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3012657lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:3012657lifeskim:mentionsumls-concept:C0262584lld:lifeskim
pubmed-article:3012657lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:3012657pubmed:issue1lld:pubmed
pubmed-article:3012657pubmed:dateCreated1986-6-27lld:pubmed
pubmed-article:3012657pubmed:abstractTextThe nature of bombesin-like immunoreactive peptides was studied in extracts of small cell carcinoma of the human lung. Three peaks, I, II and III, designated by their increasing retention times, were separated by reversed-phase high performance liquid chromatography (HPLC) with trifluoroacetic acid (TFA) as counter ion. None of the peaks corresponded to bombesin. Peak III was eluted at the same position as porcine gastrin releasing peptide (GRP) but was separated from it in another reversed-phase system using heptafluorobutyric acid (HFBA). Peak II material eluted in the position of bombesin in the HFBA system but not in the TFA system. The elution position of Peak I corresponded to that of the carboxyl terminal fragments of GRP, i.e. GRP18-27 and GRP19-27. This correspondence was observed in each of the reversed-phase and gel filtration systems used. The Peak III peptide was converted to peak I after incubation with trypsin. It was reasoned that this conversion could be one of the steps in the processing of bombesin-like peptides in human small cell carcinoma.lld:pubmed
pubmed-article:3012657pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3012657pubmed:languageenglld:pubmed
pubmed-article:3012657pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3012657pubmed:citationSubsetIMlld:pubmed
pubmed-article:3012657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3012657pubmed:statusMEDLINElld:pubmed
pubmed-article:3012657pubmed:monthMarlld:pubmed
pubmed-article:3012657pubmed:issn0167-0115lld:pubmed
pubmed-article:3012657pubmed:authorpubmed-author:SolomonSSlld:pubmed
pubmed-article:3012657pubmed:authorpubmed-author:YoshizakiKKlld:pubmed
pubmed-article:3012657pubmed:authorpubmed-author:WangN SNSlld:pubmed
pubmed-article:3012657pubmed:authorpubmed-author:TakaiIIlld:pubmed
pubmed-article:3012657pubmed:authorpubmed-author:de BockVVlld:pubmed
pubmed-article:3012657pubmed:issnTypePrintlld:pubmed
pubmed-article:3012657pubmed:volume14lld:pubmed
pubmed-article:3012657pubmed:ownerNLMlld:pubmed
pubmed-article:3012657pubmed:authorsCompleteYlld:pubmed
pubmed-article:3012657pubmed:pagination11-20lld:pubmed
pubmed-article:3012657pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3012657pubmed:meshHeadingpubmed-meshheading:3012657-...lld:pubmed
pubmed-article:3012657pubmed:meshHeadingpubmed-meshheading:3012657-...lld:pubmed
pubmed-article:3012657pubmed:meshHeadingpubmed-meshheading:3012657-...lld:pubmed
pubmed-article:3012657pubmed:meshHeadingpubmed-meshheading:3012657-...lld:pubmed
pubmed-article:3012657pubmed:meshHeadingpubmed-meshheading:3012657-...lld:pubmed
pubmed-article:3012657pubmed:meshHeadingpubmed-meshheading:3012657-...lld:pubmed
pubmed-article:3012657pubmed:meshHeadingpubmed-meshheading:3012657-...lld:pubmed
pubmed-article:3012657pubmed:year1986lld:pubmed
pubmed-article:3012657pubmed:articleTitleBombesin-like peptides in human small cell carcinoma of the lung.lld:pubmed
pubmed-article:3012657pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3012657pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3012657pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3012657lld:pubmed